Czech-BioImaging supports a newly-launched European Commission economic study to assess the current state of competition in the EU. As part of this project, the Commission has commissioned an external study to a consortium of firms of which we are part (together with Lear, E.CA Economics, Fideres, Prometeia, and the University of East Anglia). A part of this study is an external quantitative survey being conducted together with Kantar Group marketing agency. This multi-country survey is carried out among businesses in Europe's top export sectors and as potential respondents, industrial partners may get contacted to complete the survey for this study. All information companies provide in the survey will be handled with strict confidentiality and used only for the sole purpose of this study. See the document from the European Commission outlining the details of the study. Best regards CzBI Hub
Patnáctý ročník European Fourier Transform Mass Spectrometry Workshopu a čtvrtý ročník EFTMS školy se budou konat v Praze 17.-20. dubna 2024. Konference je organizována Mikrobiologickým ústavem AVČR a proběhne v budově Národní technické knihovny.
La nivel european, economia se redresează cu pai rapizi în urma recesiunii provocate de pandemie. Pe măsură ce campaniile de vaccinare progresează, restriciile impuse încep să fie ridicate, iar economiile ărilor se redeschid. Perspectivele de redresare su
projít na článekDear Czech-BioImaging users, we are thrilled to announce that Vladislav Krzyžánek, a member of the Czech-BioImaging Core Facility Electron Microscopy and Raman Spectroscopy at the Institute of Scientific Instruments of the Czech Academy of Sciences, wa
projít na článekOn 3-7 September 2016 the Dutch Techcenter for Life Sciences, the BioSB research school and ELIXIR jointly organized the fifteenth edition of the European Conference on Computational Biology. The Czech ELIXIR Node was represented by several members partic
projít na článekELIXIR, the European life science data infrastructure, is ten years old this month. The infrastructure was launched on 18 December 2013 following the ratification of the ELIXIR Consortium Agreement by five countries and EMBL (European Molecular Biology La
projít na článek